0.2(top 100%)
impact factor
69(top 100%)
papers
26(top 100%)
citations
3(top 100%)
h-index
0.2(top 100%)
extended IF
70
all documents
31
doc citations
4(top 100%)
g-index

Top Articles

#TitleJournalYearCitations
1Sleep Disordered Breathing in Pregnancy and Adverse Maternal Outcomes—A True Story?US Respiratory & Pulmonary Diseases20174
2Triple Combination Inhalers in Chronic Obstructive Pulmonary Disease and AsthmaUS Respiratory & Pulmonary Diseases20204
3Tackling ‘People Remodelling’ in Corticosteroid-dependent Asthma with Type-2 Targeting Biologics and a Formal Corticosteroid Weaning ProtocolUS Respiratory & Pulmonary Diseases20223
4Endobronchial Involvement in SarcoidosisUS Respiratory & Pulmonary Diseases20162
5Home-based Screening for Obstructive Sleep Apnea in ChildrenUS Respiratory & Pulmonary Diseases20202
6Pulmonary Alveolar Proteinosis: An Overview and Emerging TherapeuticsUS Respiratory & Pulmonary Diseases20232
7Evaluation of a Steerable Tube Thoracostomy System Compatible with a Flexible BronchoscopeUS Respiratory & Pulmonary Diseases20161
8Practice Pearls for Performing Pleural Ultrasound with Focus on Pleural Effusion and Pleural ThickeningUS Respiratory & Pulmonary Diseases20171
9Progress in the Diagnosis and Treatment of Idiopathic Pulmonary FibrosisUS Respiratory & Pulmonary Diseases20161
10Comparison of the Thin Convex Probe Endobronchial Ultrasound Bronchoscope to Standard Endobronchial Ultrasound and Flexible Bronchoscope—A Cadaveric StudyUS Respiratory & Pulmonary Diseases20171
11The Bleeding Pneumonia – A Review of Diffuse Alveolar HemorrhageUS Respiratory & Pulmonary Diseases20181
12Chronic Obstructive Pulmonary Disease—A Disease of Accelerated AgingUS Respiratory & Pulmonary Diseases20181
13Disseminated Nocardiosis Masquerading as an Obstructive Endobronchial Mass—A Case ReportUS Respiratory & Pulmonary Diseases20191
14Sleep Disorders in Neuromuscular DiseasesUS Respiratory & Pulmonary Diseases20181
15Blood Eosinophils in Chronic Obstructive Pulmonary Disease: Is There Enough Evidence?US Respiratory & Pulmonary Diseases20211
16Updates in the Management of Alpha-1 Antitrypsin Deficiency Lung DiseaseUS Respiratory & Pulmonary Diseases20211
17Is Janus Kinase Inhibition the Future of the Management of Rheumatoid Arthritis-associated Interstitial Lung Disease?US Respiratory & Pulmonary Diseases20221
18Innovations in Bronchoscopy: Robotic-assisted BronchoscopyUS Respiratory & Pulmonary Diseases20221
19Ensifentrine: A First-in-class Bifunctional Drug for the Treatment of Chronic Obstructive Pulmonary DiseaseUS Respiratory & Pulmonary Diseases20221
20Future Directions in Chronic CoughUS Respiratory & Pulmonary Diseases20231
21Case Report—Aspergillus Empyema Necessitans Post Double-lung TransplantUS Respiratory & Pulmonary Diseases20160
22The Role of Noninvasive Measurement of Airway Inflammation in Asthma and Chronic Obstructive Pulmonary DiseaseUS Respiratory & Pulmonary Diseases20160
23Respiratory Care of the Morbidly Obese PatientUS Respiratory & Pulmonary Diseases20160
24New Developments in Mechanical VentilationUS Respiratory & Pulmonary Diseases20170
25A Snapshot of Grassroots Primary Care and Tuberculosis Control in India—a US Fulbright–Nehru Scholar Program ExperienceUS Respiratory & Pulmonary Diseases20170
26Sleep Apnea Increases Brain Amyloid Burden in the Early Preclinical Stages of Alzheimer’s Disease—A Potential New Therapeutic Target?US Respiratory & Pulmonary Diseases20170
27Call for Submissions 2018US Respiratory & Pulmonary Diseases20170
28Fighting COPD Together—The COPD National Action PlanUS Respiratory & Pulmonary Diseases20170
29Lung Sequestration in an Octogenarian MaleUS Respiratory & Pulmonary Diseases20170
30Diffuse Panbronchiolitis is not Restricted to East Asia—a Mini Literature ReviewUS Respiratory & Pulmonary Diseases20170
31Nontuberculous Mycobacterial Pulmonary InfectionsUS Respiratory & Pulmonary Diseases20180
32Updates in the Guidelines and Treatment of Ventilator-dependent ChildrenUS Respiratory & Pulmonary Diseases20180
33Relevance and the Dissemination of Medical Literature in the Information AgeUS Respiratory & Pulmonary Diseases20180
34Waterpipe Tobacco Smoking and the Lungs – Short NoticeUS Respiratory & Pulmonary Diseases20180
35Underdiagnosis of Asthma in Syrian Shelters in Conflict Zones–Highlighting the Need for a Healthcare Training ProgramUS Respiratory & Pulmonary Diseases20180
36The Use of Sweetened and Flavored Electronic Cigarettes Among Young People—A Growing ConcernUS Respiratory & Pulmonary Diseases20190
37Lessons from the Outbreak of E-cigarette-associated Lipoid Pneumonia in North CarolinaUS Respiratory & Pulmonary Diseases20190
38Inhaled Corticosteroid Therapy—The Impact of Formulary Changes on Asthma ControlUS Respiratory & Pulmonary Diseases20190
39Elexacaftor-tezacaftor-ivacaftor—A Combination Therapy for Phe508del Cystic FibrosisUS Respiratory & Pulmonary Diseases20190
40Impact of Smoking and Tobacco Use on the Severity of COVID-19 InfectionUS Respiratory & Pulmonary Diseases20200
41COVID-19 Pandemic—Allergen-specific Immunotherapy Positioning in Respiratory AllergyUS Respiratory & Pulmonary Diseases20200
42Considering the Impact of Type 2 Diabetes Mellitus—Biological Mechanisms in COVID-19 PathologyUS Respiratory & Pulmonary Diseases20200
43Dupilumab—A Potential New Biologic for Chronic Rhinosinusitis with Nasal PolypsUS Respiratory & Pulmonary Diseases20200
44Improvement of Chest Wall Compliance Immediately Following Subcutaneous Placement of Central Venous Catheter for Decompression of Massive Subcutaneous EmphysemaUS Respiratory & Pulmonary Diseases20200
45Aging and Respiratory DiseasesUS Respiratory & Pulmonary Diseases20200
46Obesity Hypoventilation Syndrome—A Concise Clinical ReviewUS Respiratory & Pulmonary Diseases20200
47Nintedanib—A Potential New Therapy for Systemic Sclerosis-associated Interstitial Lung DiseaseUS Respiratory & Pulmonary Diseases20200
48Non-tuberculous Mycobacteria Infection: A Neglected Disease in BangladeshUS Respiratory & Pulmonary Diseases20210
49Proton Pump Inhibitors and Risk of Infection: Is Suppression of Immune Defence Molecules to Blame?US Respiratory & Pulmonary Diseases20210
50Nirsevimab: An Extended Half-life Monoclonal Antibody for the Prevention of Infant Respiratory Syncytial Virus InfectionUS Respiratory & Pulmonary Diseases20210